The US Secretary of Health and Human Services, RFK Jr., removing all 17 members of a panel that makes vaccine policy recommendations to the CDC. They're expected to be replaced by new members who are currently under consideration and here to talk about the potential ramifications. We have Yahoo Finance senior health reporter, Anjali Kamlani. Anjali, what do we know and ultimately, what is the signal to some of the publicly traded companies who rely on some stability within the CDC?

Yeah, we've already seen both the FDA and the CDC go through a little bit of changes. We've seen other advisory groups maybe be fired and brought back. So, right now, things are a little bit up in the air. But what we do know, especially from some of the insiders I spoke to, is that the CDC advisory committee for vaccines, RFK Jr. is really focused on trying to put in people who will maybe change the tone of how it operates. So, just to remind you, the FDA is the regulatory body that approves the vaccines. So, the approvals are not currently in jeopardy. And the FDA has its own vaccine advisory committee that helps to talk through whether or not this vaccine is safe and and is useful and should be approved, and they make that recommendation to the FDA. Meanwhile, the CDC's panel, uh, it determines who should be given the vaccine, who is it safe for, who is vulnerable, which populations are vulnerable, and who actually needs these vaccines. That is the panel that just got fired. Could we see some reappearances based on the history of how these firings have been going? Possible. Some insiders I spoke to said that uh the process for these new applicants is very different. They're actually not applicants. They're being sought by RFK Jr. and his team. And so that really spins what we're looking at in terms of what the purpose of these of this committee could be. We know that uh if you take a look at Project 2025, we know that has been referenced multiple times in terms of action from the Trump administration, and in there it says by statute or regulation, CDC guidance must be prohibited from taking a prescriptive character. And that language does match what we've heard from RFK Jr., a known anti-vaccination individual, who has been pushing for rolling back the childhood vaccine schedule and making it more about personal choice, more individual choice, parental choice, and even physician choice about what vaccines kids should be taking. And so, it's likely we're going to see that interrupt of it. I've had conversations also with vaccine companies in the recent past, talking about what they expect. And the truth is that while this this will actually disrupt the flow of bringing uh uh vaccine to market, we have had some of what I would what was termed the big ones already on the market. And so, this is more of what are the new ones, what are some areas that, you know, long projects of bringing vaccines to market are still are still needed, and it doesn't have a very large uh impact on some of these vaccine companies. Notably the big ones in the in the game are Pfizer, GSK, Sanofi, as well as, you know, Moderna and Merck. And so, these are the companies that could be impacted in the future as they look to try and bring new products to market. But the fact that there are also companies we've seen in the recent past jump out of the vaccine game also tells you sort of where, you know, where the needle is pointed in terms of vaccines being a product that maybe aren't as big revenue, aren't as big volume, aren't as big uh uh uh uh product for these companies.